WO2007048223A3 - Systeme d'administration de medicaments a retention gastrique - Google Patents

Systeme d'administration de medicaments a retention gastrique Download PDF

Info

Publication number
WO2007048223A3
WO2007048223A3 PCT/CA2006/001706 CA2006001706W WO2007048223A3 WO 2007048223 A3 WO2007048223 A3 WO 2007048223A3 CA 2006001706 W CA2006001706 W CA 2006001706W WO 2007048223 A3 WO2007048223 A3 WO 2007048223A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery system
drug delivery
gastric retention
matrix component
intermingled
Prior art date
Application number
PCT/CA2006/001706
Other languages
English (en)
Other versions
WO2007048223A2 (fr
Inventor
Jack Aurora
Vinayak Sant
Original Assignee
Pharmascience Inc
Jack Aurora
Vinayak Sant
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/257,361 external-priority patent/US20070092565A1/en
Priority claimed from CA 2524422 external-priority patent/CA2524422A1/fr
Application filed by Pharmascience Inc, Jack Aurora, Vinayak Sant filed Critical Pharmascience Inc
Priority to EP06804634A priority Critical patent/EP1957052A2/fr
Publication of WO2007048223A2 publication Critical patent/WO2007048223A2/fr
Publication of WO2007048223A3 publication Critical patent/WO2007048223A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un système d'administration de médicaments à rétention gastrique (c.-à-d. une forme pharmaceutique à libération contrôlée) formulé pour favoriser la rétention de la forme pharmaceutique dans le tractus gastro-intestinal supérieur et en particulier dans l'estomac.
PCT/CA2006/001706 2005-10-25 2006-10-17 Systeme d'administration de medicaments a retention gastrique WO2007048223A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP06804634A EP1957052A2 (fr) 2005-10-25 2006-10-17 Systeme d'administration de medicaments a retention gastrique

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/257,361 US20070092565A1 (en) 2005-10-25 2005-10-25 Gastric retention drug delivery system
US11/257,361 2005-10-25
CA 2524422 CA2524422A1 (fr) 2005-10-25 2005-10-25 Dispositif d'administration de medicament a retention gastrique
CA2,524,422 2005-10-25

Publications (2)

Publication Number Publication Date
WO2007048223A2 WO2007048223A2 (fr) 2007-05-03
WO2007048223A3 true WO2007048223A3 (fr) 2007-06-14

Family

ID=37968169

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CA2006/001706 WO2007048223A2 (fr) 2005-10-25 2006-10-17 Systeme d'administration de medicaments a retention gastrique

Country Status (2)

Country Link
EP (1) EP1957052A2 (fr)
WO (1) WO2007048223A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010258345A1 (en) * 2009-06-12 2012-01-19 Micro Labs Limited Novel pharmaceutical compositions containing pregabalin
EP2361615A1 (fr) 2010-02-19 2011-08-31 Alfred E. Tiefenbacher GmbH & Co. KG Comprimé à libération prolongée de dipyridamole
EP2568969A2 (fr) * 2010-05-11 2013-03-20 Cima Labs Inc. Formulations résistantes à l'alcool
EP2415460A1 (fr) * 2010-08-03 2012-02-08 ratiopharm GmbH Formulations pour l'administration orale de prégabaline
WO2013100874A1 (fr) * 2011-12-19 2013-07-04 Mahmut Bilgic Formulation de prégabline effervescente
WO2013109199A1 (fr) * 2011-12-19 2013-07-25 Mahmut Bilgic Formulations pharmaceutiques effervescentes comprenant de la prégabaline et de la vitamine b12
EP2698144A1 (fr) * 2012-08-12 2014-02-19 Ali Raif Ilaç Sanayi ve Ticaret Anonim Sirketi Formulation de comprimé à libération prolongée contenant de la gabapentine dont l'aptitude à rester dans l'estomac est améliorée
EP3099288A1 (fr) * 2014-01-28 2016-12-07 Sun Pharmaceutical Industries Ltd Comprimés à rétention gastrique stabilisée de prégabaline
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
CA2951909C (fr) 2014-06-11 2022-08-16 Massachusetts Institute Of Technology Dispositifs a demeure auto-assembles, et procedes associes
JP2018515476A (ja) 2015-05-01 2018-06-14 マサチューセッツ インスティテュート オブ テクノロジー 誘発性形状記憶誘導デバイス
CN108472249A (zh) 2015-10-23 2018-08-31 林德拉有限公司 用于治疗剂缓释的胃驻留系统及其使用方法
EP3386488B1 (fr) 2015-12-08 2023-09-06 Lyndra Therapeutics, Inc. Configurations géométriques de systèmes à résidence gastrique
CN110022861B (zh) 2016-09-30 2024-06-28 林德拉治疗公司 用于金刚烷类药物缓释的胃驻留系统
WO2018227147A1 (fr) 2017-06-09 2018-12-13 Lyndra, Inc. Systèmes gastriques à demeure avec films modulant le taux de libération
CN113521023B (zh) * 2021-07-16 2023-04-25 昆明理工大学 一种紫胶树脂基胃内漂浮滞留载药系统的制备方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941064A1 (fr) * 1996-11-17 1999-09-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem PREPARATIONS PHARMACEUTIQUES SERVANT A EFFECTUER LA LIBERATION CONTROLEE D'ANTIBIOTIQUES DE beta-LACTAME
CA2452738A1 (fr) * 2001-07-04 2003-02-13 Sun Pharmaceutical Industries Limited Systeme d'administration regulee de medicament a retention gastrique
WO2003026637A2 (fr) * 2001-09-28 2003-04-03 Sun Pharmaceutical Industries Limited Forme posologique pour traiter le diabete sucre
WO2004032906A1 (fr) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Forme gastro-retentive pour administrer du levodopa
US6861072B1 (en) * 1998-10-16 2005-03-01 Sanofi-Synthelabo Pharmaceutical composition with gastric residence and controlled release
WO2005060942A1 (fr) * 2003-12-19 2005-07-07 Aurobindo Pharma Ltd Composition pharmaceutique de metformine a liberation prolongee
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
US20060165745A1 (en) * 2005-01-21 2006-07-27 Yiwen Chew Sustained release tablets for treatment of aqueous environment and methods for making the same

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941064A1 (fr) * 1996-11-17 1999-09-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem PREPARATIONS PHARMACEUTIQUES SERVANT A EFFECTUER LA LIBERATION CONTROLEE D'ANTIBIOTIQUES DE beta-LACTAME
US6861072B1 (en) * 1998-10-16 2005-03-01 Sanofi-Synthelabo Pharmaceutical composition with gastric residence and controlled release
CA2452738A1 (fr) * 2001-07-04 2003-02-13 Sun Pharmaceutical Industries Limited Systeme d'administration regulee de medicament a retention gastrique
WO2003026637A2 (fr) * 2001-09-28 2003-04-03 Sun Pharmaceutical Industries Limited Forme posologique pour traiter le diabete sucre
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
WO2004032906A1 (fr) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Forme gastro-retentive pour administrer du levodopa
WO2005060942A1 (fr) * 2003-12-19 2005-07-07 Aurobindo Pharma Ltd Composition pharmaceutique de metformine a liberation prolongee
US20060165745A1 (en) * 2005-01-21 2006-07-27 Yiwen Chew Sustained release tablets for treatment of aqueous environment and methods for making the same

Also Published As

Publication number Publication date
EP1957052A2 (fr) 2008-08-20
WO2007048223A2 (fr) 2007-05-03

Similar Documents

Publication Publication Date Title
WO2007048223A3 (fr) Systeme d'administration de medicaments a retention gastrique
WO2007013975A3 (fr) Compositions et procedes destines a controler l'abus de medicaments
WO2007044906A3 (fr) Préparations et méthodes pour l'augmentation de la stabilité gastro-intestinale d'oligopeptides et de polypeptides
WO2005112896A3 (fr) Forme posologique permettant l'administration de multiples formes medicamenteuses
WO2007143155A3 (fr) Forme pharmaceutique à liberation prolongée contenant de la phényléphrine
WO2008060964A3 (fr) Procédés d'administration de médications pour la perte de poids
AR062583A1 (es) Sistema de suministro de farmaco oral gastro-retentivo de liberacion extendida para valsartan
WO2010062688A3 (fr) Forme galénique pour insertion dans la bouche
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
WO2009063222A3 (fr) Compositions solides
WO2006035417A3 (fr) Preparations de dihydropyrimidine
WO2008058288A3 (fr) Formulations de méthotrexate à libération prolongée et procédés d'utilisation
EP2792349A3 (fr) Compositions pharmaceutiques à libération contrôlée comportant un ester d'acide fumarique
EP3492069A3 (fr) Compositions pharmaceutiques
WO2007031887A3 (fr) Composition pharmaceutique de metformine a liberation lente et procede de production correspondant
CL2009002073A1 (es) Composicion farmaceutica solida para la liberacion controlada de un agente activo activo en el tracto gastrointestinal que comprende al menos un agente acido con solubilidad de menos de 0,3 mg/ml en solucion acuosa a un ph alrededor del pka del agente acido, un polimero hidrofilo, un alcanizador; uso en trastornos cardiovasculares.
GEP20104896B (en) Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
WO2008011177A3 (fr) Système de délivrance de substances médicinales et procédés connexes
WO2004064815A8 (fr) Formulation de dosage oral
WO2010103365A3 (fr) Composition à libération lente d'un agent thérapeutique
EP2386295A3 (fr) Comprimes a liberation gastro-intestinale du principe actif regulee en foction du temps et du site
WO2007035515A3 (fr) Procede d'augmentation d'une exposition intraepitheliale et systemique a des agents therapeutiques ayant une activite de substrat pour les enzymes p450 cytochromes, et systemes d'ecoulements membranaires par voie vaginale ou orale
WO2010020856A3 (fr) Administration modulée de médicaments depuis un dispositif d’administration composite
WO2006008173A3 (fr) Formulations pharmaceutiques
WO2007144169A3 (fr) Dérivés d'entacapone

Legal Events

Date Code Title Description
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2006804634

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWP Wipo information: published in national office

Ref document number: 2006804634

Country of ref document: EP

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)